Hamilton Lane Incorporated (HLNE)

ShockWave Medical Stock Forecast

Stock Price Forecast

The 7 analysts that cover ShockWave Medical stock have a consensus rating of "Hold" and an average price target of $158.57, which forecasts a 2.49% increase in the stock price over the next year. The lowest target is $139 and the highest is $185.

Price Target: $158.57 (+2.49%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$139	$158.57	$157	$185
Change	-10.15%	+2.49%	+1.48%	+19.58%

Analyst Ratings

The average analyst rating for ShockWave Medical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	7	6	5	5	5	6
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	8	7	6	6	6	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kenneth Worthington JP Morgan	JP Morgan	Hold Maintains $153 → $145	Hold	Maintains	$153 → $145	-6.28%	Jul 23, 2025
Michael Brown Wells Fargo	Wells Fargo	Hold Maintains $161 → $162	Hold	Maintains	$161 → $162	+4.71%	Jul 11, 2025
Kyle Voigt Keefe, Bruyette & Woods	Keefe, Bruyette & Woods	Hold Maintains $162 → $155	Hold	Maintains	$162 → $155	+0.19%	Jun 2, 2025
Michael Brown Wells Fargo	Wells Fargo	Hold Maintains $166 → $161	Hold	Maintains	$166 → $161	+4.07%	May 30, 2025
Michael Brown Wells Fargo	Wells Fargo	Hold Maintains $147 → $166	Hold	Maintains	$147 → $166	+7.30%	May 23, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

713.62M

Increased by 0.09%

from 712.96M

Revenue Next Year

844.56M

Increased by 18.35%

from 713.62M

EPS This Year

4.57

Decreased by -15.57%

from 5.41

EPS Next Year

5.70

Increased by 24.89%

from 4.57

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027	Mar 31, 2028
Revenue	341.64M	367.92M	528.75M	553.84M	712.96M	713.62M	844.56M	1.01B
Revenue Growth	24.66%	7.69%	43.72%	4.75%	28.73%	0.09%	18.35%	19.83%
EPS	2.81	3.98	3.01	3.69	5.41	4.57	5.70	6.62
EPS Growth	30.44%	41.91%	-24.36%	22.67%	46.35%	-15.57%	24.89%	16.19%
Forward PE	-	-	-	-	-	33.89	27.13	23.35
No. Analysts	-	-	-	-	-	8	7	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	763.2M	907.8M	1.0B
Avg	713.6M	844.6M	1.0B
Low	623.3M	756.7M	969.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	7.1%	27.2%	23.7%
Avg	0.1%	18.3%	19.8%
Low	-12.6%	6.0%	14.7%

EPS Forecast

EPS	2026	2027	2028
High	4.94	5.93	6.88
Avg	4.57	5.70	6.62
Low	4.10	5.35	6.31

EPS Growth

EPS Growth	2026	2027	2028
High	-8.7%	29.9%	20.6%
Avg	-15.6%	24.9%	16.2%
Low	-24.2%	17.2%	10.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.